Active Ingredient(s):Alglucerase FDA Approved: * April 5, 1991 Pharm Company: *GENZYME Category:Enzymes
Alglucerase was a biopharmaceutical drug for the treatment of Gaucher's disease. It was a modified form of human β-glucocerebrosidase enzyme, where the non-reducing ends of the oligosaccharide chains have been terminated with mannose residues.
Ceredase is the trade name of a citrate buffered solution of alglucerase that was manufactured by Genzyme Corporation from human placental tissue. It is given intravenously in the treatment of Type 1 Gaucher'...
* May have multiple approval dates, manufacturers, or labelers.